Drug
Diazoxide choline clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 4
- first study started
- 2008
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 4
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Studies
Open first, then newest update. How each study uses diazoxide choline is read from its arms, and is right about nine times in ten.
Testing it · 10
- Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeCompletedPhase 3Soleno Therapeutics, Inc.NCT05701774Written as DCCR
- An Open-Label Study of Diazoxide Choline in Patients With Genetic ObesitiesWithdrawnPhase 2Soleno Therapeutics, Inc.NCT05532020Written as DCCR (diazoxide choline) extended-release tablets
- Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal PeriodCompletedPhase 3Soleno Therapeutics, Inc.NCT03714373Written as DCCR
- A Study of Diazoxide Choline in Patients With Prader-Willi SyndromeCompletedPhase 3Soleno Therapeutics, Inc.NCT03440814Written as DCCR
- An Open-Label Study of DCCR Tablet in Patients With PWSWithdrawnPhase 3Soleno Therapeutics, Inc.NCT04086810Written as DCCR
- A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)Status unknownPhase 2Essentialis, Inc.NCT02893618Written as Diazoxide choline controlled-release tablet
- Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi SyndromeCompletedPhase 1/2Essentialis, Inc.NCT02034071Written as DCCR
- Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide CholineWithdrawnPhase 1Essentialis, Inc.NCT00901823Written as Diazoxide choline
- Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated FormulationsCompletedPhase 1Essentialis, Inc.NCT00688857Written as Diazoxide choline
- Diazoxide Choline in HypertriglyceridemiaCompletedPhase 2Essentialis, Inc.NCT00696475Written as Diazoxide choline
Codes
What other systems call diazoxide choline · ClinicalTrials.gg INT002148
- MeSH (NLM) C000731842diazoxide cholineOne source NLM
- UNII (FDA) 2U8NRZ7P8LDIAZOXIDE CHOLINEConfirmed FDA, NLM, Wikidata
- Wikidata Q27255610diazoxide cholineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C213384Diazoxide CholineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000731842 | diazoxide choline | One source NLM |
| UNII (FDA) | 2U8NRZ7P8L | DIAZOXIDE CHOLINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27255610 | diazoxide choline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C213384 | Diazoxide Choline | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.